A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responsesDavid C. Jackson, Lorena E. Brown, Georgia Deliyannis et al.|Proceedings of the National Academy of Sciences|2004Cited by 235
Synergism between active listeriolysin O and dimethyldioctadecylammonium bromide to activate CD8+ T cellsCorey Smith, Christina Cheers|Vaccine|2005Cited by 3